UA107356C2 - Oxazine derivatives and their use as bace inhibitors for the treatment of neurological disorders - Google Patents

Oxazine derivatives and their use as bace inhibitors for the treatment of neurological disorders

Info

Publication number
UA107356C2
UA107356C2 UAA201200736A UAA201200736A UA107356C2 UA 107356 C2 UA107356 C2 UA 107356C2 UA A201200736 A UAA201200736 A UA A201200736A UA A201200736 A UAA201200736 A UA A201200736A UA 107356 C2 UA107356 C2 UA 107356C2
Authority
UA
Ukraine
Prior art keywords
treatment
neurological disorders
oxazine derivatives
bace inhibitors
bace
Prior art date
Application number
UAA201200736A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Sangamesh Badiger
Murali Chebrolu
Mathias Frederiksen
Philipp Holzer
Konstanze Hurth
Rainer Martin Lueoend
Rainer Machauer
Henrik Moebitz
Ulf Neumann
Rita Ramos
Heinrich Rueeger
Michael Schaefer
Marina Tintelnot-Blomley
Siem Jacob Veenstra
Markus Voegtle
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Priority claimed from PCT/EP2010/060718 external-priority patent/WO2011009943A1/en
Publication of UA107356C2 publication Critical patent/UA107356C2/en

Links

Abstract

В заявці описані нові гетероциклічні сполуки формули, (I)у якій всі перемінні є такими, як визначено в описі, у вільній формі або у формі солі, їх одержання, їх застосування у медицині та лікарські засоби, що містять їх.The application describes novel heterocyclic compounds of formula (I) in which all the variables are as defined in the description, in free or salt form, their preparation, their use in medicine, and the medicines containing them.

UAA201200736A 2009-07-24 2010-07-23 Oxazine derivatives and their use as bace inhibitors for the treatment of neurological disorders UA107356C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22847209P 2009-07-24 2009-07-24
PCT/EP2010/060718 WO2011009943A1 (en) 2009-07-24 2010-07-23 Oxazine derivatives and their use as bace inhibitors for the treatment of neurological disorders

Publications (1)

Publication Number Publication Date
UA107356C2 true UA107356C2 (en) 2014-12-25

Family

ID=52680428

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201200736A UA107356C2 (en) 2009-07-24 2010-07-23 Oxazine derivatives and their use as bace inhibitors for the treatment of neurological disorders

Country Status (2)

Country Link
TN (1) TN2011000668A1 (en)
UA (1) UA107356C2 (en)

Also Published As

Publication number Publication date
TN2011000668A1 (en) 2013-05-24

Similar Documents

Publication Publication Date Title
EA201200174A1 (en) OXAZIN DERIVATIVES AND THEIR APPLICATION AS BACE INHIBITORS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
EA201200952A1 (en) DERIVATIVES OF PYRAZINE AND THEIR APPLICATION FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
EA201200176A1 (en) OXAZIN DERIVATIVES AND THEIR APPLICATION FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
EA201391029A1 (en) OXAZIN DERIVATIVES AND THEIR APPLICATION IN THE TREATMENT OF NEUROLOGICAL DISORDERS
UA113051C2 (en) HETEROCYCLIC DERIVATIVES AND THEIR APPLICATIONS IN THE TREATMENT OF NEUROLOGICAL DISORDERS
TN2014000138A1 (en) Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases.
MX343706B (en) Novel heterocyclic derivatives.
MX347241B (en) Aminopyrimidine derivatives for use as modulators of kinase activity.
EA201490888A1 (en) NEW PURIN DERIVATIVES AND THEIR APPLICATION FOR THE TREATMENT OF DISEASE
GEP20135964B (en) Inhibitors of beta-secretase
EA201190158A1 (en) Derivatives of benzofuranyl for use as glucose kinase inhibitors
IN2014DN03206A (en)
JO3007B1 (en) Compounds and compositions as protein kinase inhibitors
MX2014000964A (en) Substituted heterocyclic aza derivatives.
MX2013014194A (en) Cyclopropyl-fused-1,3-thiazepines as bace 1 and/or bace 2 inhibitors.
MA32723B1 (en) Anilino-pyrimidine derivatives substituted with sulfoximine marked as CDK inhibitors, their preparation and use as drugs
UA109290C2 (en) Common Crystals and Salts of CCR3 Inhibitors
MX2012007582A (en) 4-phenoxy-nicotinamide or 4-phenoxy-pyrimidine-5-carboxamide compounds.
NZ702254A (en) 5-amino[1,4]thiazines as bace 1 inhibitors
MX2013002208A (en) Sulfonylpiperazine derivatives that interact with glucokinase regulatory protein for the treatment of diabetes.
MX2010002007A (en) Aminobenzyl-substituted cyclic sulfones useful as bace inhibitors.
MX2009004625A (en) 3-amino-pyrazole-4-carboxamide derivatives useful as inhibitors of protein kinases.
MX2013011561A (en) Benzodioxepine and benzodioxine compounds that interact with glucokinase regulatory protein for the treatment of diabetes.
UA107356C2 (en) Oxazine derivatives and their use as bace inhibitors for the treatment of neurological disorders
TN2012000370A1 (en) 5-alkynyl pyrimidines and their use as kinase inhibitors